UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 5)*
MARYLAND FEDERAL BANCORP, INC
(Name of Issuer)
Common Stock $.01 par value
(Title of Class of Securities)
574061107
(CUSIP Number)
Robert I. Schattner,5901 Montrose Rd,Rockville,MD 20852;301-231-7700
(Name, Address and Telephone Number of Person Authorized to Receive
Notices and Communications)
May 20, 1998
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(b)(3) or (4), check the
following box [ ].
Check the following box if a fee is being paid with the statement [ ].
(A fee is not required only if the reporting person: (1) has a previous
statement on file reporting beneficial ownership of more than five
percent of the class of securities described in Item 1: and (2) has
filed no amendment subsequent thereto reporting beneficial ownership of
five percent or less of such class.) (See Rule 13d-7)
Note: Six copies of this statement, including all exhibits, should be
filed with the Commission. See Rule 13d-1(a) for other parties to whom
copies are to be sent.
The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
<PAGE>
SCHEDULE 13D
CUSIP NO. 574061107 Page 2 of 4 pages
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Robert I. Schattner SS# ###-##-####
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
Not Applicable
3. SEC USE ONLY
4. SOURCE OF FUNDS*
Personal Funds - PF
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
6. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
7. SOLE VOTING POWER
NUMBER OF 529,888 shares
SHARES ______________________________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY None
EACH ______________________________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON 529,888 shares
WITH _______________________________________________
10.SHARED DISPOSITIVE POWER
None
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
529,888 shares
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* [ ]
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
8.176 %
14. TYPE OF REPORTING PERSON *
Individual - IN
<PAGE>
SCHEDULE 13D
CUSIP NO. 574061107 Page 3 of 4 pages
Item 1. Security and Issuer
This Amendment #5 to Schedule 13D relates to shares of Common
Stock, $.01 par value ("Shares") of Maryland Federal Bancorp, Inc (the
"Company"). The address of the Company's principal executive offices is
3505 Hamilton Street, Hyattsville, Maryland 20782.
Item 2. Identity and Background
This Amendment #5 to Schedule 13D is filed by the following
individual :
Principal Principal
Name and Address Occupation Business
Robert I. Schattner President Sporicidin International
5901 Montrose Road Pharmaceutical Research 5901 Montrose Road
Suite 1200S and Development Suite 1200S
Rockville, MD 20852 Rockville, MD 20852
The natural person by whom this Amendment #5 to Schedule 13D is
filed (the "Reporting Person"), during the last five years, (a) has not
been convicted in a criminal proceeding (excluding traffic violations or
similar misdemeanors) or (b) was not a party to a civil proceeding of a
judicial or administrative body of competent jurisdiction and as a
result of such proceedings was or is subject to a judgment, decree or
final order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or finding any
violation with respect to such laws.
Item 3. Source and Amount of Funds or Other Consideration
All of the funds used by the Reporting Person in purchasing the
Shares were personal funds of the Reporting Person. Shares were
acquired at various times since 1987.
Item 4. Purpose of Transaction
The Reporting Person holds the securities of the Issuer for
investment purposes. The Reporting Person has no present plans to
purchase or dispose of any additional Shares, although he may, in the
future, decide to purchase or dispose of additional shares. The
Reporting Person has no plans or proposals that would result in any of
the events listed in subparagraphs (a) through (j) of Item 4.
<PAGE>
SCHEDULE 13D
CUSIP NO. 574061107 Page 4 of 4 pages
Item 5. Interest in Securities of Issuer
Set forth below is information relating to any beneficial
ownership of Shares by each Reporting Person.
____ Number of Shares
Voting Power Investment Power Total (percent)
Name Sole Shared Sole Shared of Shrs Outstd
Robert I. Schattner 529,888 -0- 529,888 -0- 529,888 (8.176%)
Item 6. Contracts, Arrangements, Understandings of Relationships with
Respect to Securities of the Issuer.
The Reporting Person has no contracts, arrangements,
understandings or relationships with any other person, company or other
entity relating to the transfer or voting of Shares or other matters
enumerated under Item 6 of Schedule 13D.
Item 7. Material to be Filed as Exhibits.
None
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is
complete and correct.
Date: June 4, 1998
s/Robert I. Schattner
Robert I. Schattner
